PAHC Stock Overview
Operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 3/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 4/6 |
Rewards
Risk Analysis
Phibro Animal Health Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$19.46 |
| 52 Week High | US$22.31 |
| 52 Week Low | US$9.40 |
| Beta | 0.52 |
| 11 Month Change | 10.51% |
| 3 Month Change | 14.94% |
| 1 Year Change | 54.81% |
| 33 Year Change | -13.89% |
| 5 Year Change | -9.07% |
| Change since IPO | 14.47% |
Recent News & Updates
Phibro Animal Health (NASDAQ:PAHC) Has Affirmed Its Dividend Of $0.12
Aug 29
Phibro Animal Health (NASDAQ:PAHC) Will Pay A Dividend Of $0.12
Aug 15Recent updates
Phibro Animal Health (NASDAQ:PAHC) Has Affirmed Its Dividend Of $0.12
Aug 29Phibro Animal Health (NASDAQ:PAHC) Will Pay A Dividend Of $0.12
Aug 15New Forecasts: Here's What Analysts Think The Future Holds For Phibro Animal Health Corporation (NASDAQ:PAHC)
May 14Phibro Animal Health (NASDAQ:PAHC) Is Paying Out A Dividend Of $0.12
May 11Phibro Animal Health: An Interesting Deal With Zoetis For A Struggling Business
May 01Market Participants Recognise Phibro Animal Health Corporation's (NASDAQ:PAHC) Earnings Pushing Shares 30% Higher
Apr 30Phibro Animal Health (NASDAQ:PAHC) Is Due To Pay A Dividend Of $0.12
Feb 10Phibro Animal Health (NASDAQ:PAHC) Use Of Debt Could Be Considered Risky
Dec 06Phibro Animal Health's (NASDAQ:PAHC) Dividend Will Be $0.12
Nov 10A Look At The Fair Value Of Phibro Animal Health Corporation (NASDAQ:PAHC)
Nov 05Phibro Animal Health (NASDAQ:PAHC) Has Affirmed Its Dividend Of $0.12
Aug 28Phibro Animal Health (NASDAQ:PAHC) Is Paying Out A Dividend Of $0.12
Jul 29Phibro Animal Health (NASDAQ:PAHC) Is Due To Pay A Dividend Of $0.12
Feb 10Is Phibro Animal Health Corporation (NASDAQ:PAHC) Worth US$13.8 Based On Its Intrinsic Value?
Dec 23Phibro Animal Health's (NASDAQ:PAHC) Dividend Will Be $0.12
Aug 26Phibro Animal Non-GAAP EPS of $0.36 misses by $0.02, revenue of $255.3M beats by $5.26M
Aug 24Is Phibro Animal Health (NASDAQ:PAHC) A Risky Investment?
Aug 24Phibro Animal Health (NASDAQ:PAHC) Has Affirmed Its Dividend Of $0.12
Jul 29Phibro Animal declares $0.12 dividend
Jul 25Phibro Animal Health's (NASDAQ:PAHC) Dividend Will Be US$0.12
May 06Phibro Animal Health (NASDAQ:PAHC) Has Announced A Dividend Of US$0.12
Feb 11Shareholder Returns
| PAHC | US Pharmaceuticals | US Market | |
|---|---|---|---|
| 7D | -7.3% | -3.1% | -4.4% |
| 1Y | 54.8% | 16.1% | 19.1% |
Return vs Industry: PAHC exceeded the US Pharmaceuticals industry which returned 16.1% over the past year.
Return vs Market: PAHC exceeded the US Market which returned 19.1% over the past year.
Price Volatility
| PAHC volatility | |
|---|---|
| PAHC Average Weekly Movement | 6.4% |
| Pharmaceuticals Industry Average Movement | 10.1% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 14.9% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: PAHC has not had significant price volatility in the past 3 months.
Volatility Over Time: PAHC's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1946 | 1,940 | Jack Bendheim | www.pahc.com |
Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.
Phibro Animal Health Corporation Fundamentals Summary
| PAHC fundamental statistics | |
|---|---|
| Market cap | US$788.20m |
| Earnings (TTM) | US$2.42m |
| Revenue (TTM) | US$1.02b |
326.2x
P/E Ratio0.8x
P/S RatioIs PAHC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| PAHC income statement (TTM) | |
|---|---|
| Revenue | US$1.02b |
| Cost of Revenue | US$704.07m |
| Gross Profit | US$313.61m |
| Other Expenses | US$311.20m |
| Earnings | US$2.42m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.06 |
| Gross Margin | 30.82% |
| Net Profit Margin | 0.24% |
| Debt/Equity Ratio | 192.2% |
How did PAHC perform over the long term?
See historical performance and comparison